MITRE

Trial description
Microbiome Immunotherapy Toxicity and Response Evaluation (MITRE) An observational study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy
Contact name
Dr Pippa Corrie
Trial start date
Tuesday, March 30, 2021
Trial end date
Tuesday, December 31, 2024
Trial tumour type
Kidney
Show on Radiotherapy
No